The Cure (2016)

Experimental hop wheat I.P.A. CBC is proud to brew and release The Cure as one of 100 craft brewers across the U.S. participating in the Ales for ALS™ campaign. We support ALS TDI’s mission to discover and develop effective treatments for ALS, commonly known as Lou Gehrig’s disease. Ales for ALS™ is a unique craft brewery-based fundraising initiative created to accelerate drug development for ALS patients today. [wpex more="Read more" less="Read less"] As part of the program, participant brewers receive a special blend of experimental hops donated by B.T. Loftus Ranches and Hopunion. What are “experimental hops?” They are new varietals from the hop breeding program which have not yet been named and made available commercially to the brewing world. Five different varietals were chosen and blended for this beer by our good friends Rob Kent, Ken and Brian Grossman, Julian Schrago, and John Mallett, of the Bear Republic, Sierra Nevada, Beechwood BBQ and Brewing, and Bell’s breweries. From these hops, each brewer will brew a unique beer and donate a portion of the sales to ALS TDI. CBC’s contribution, “The Cure” 2016 is a wheat IPA which balances pronounced citrus and fruity aromas of lime and mango from the hops with the soft flavor of wheat malt. Lighter hop notes of spice and resin add layers of complexity to this radiant golden colored beer. Many people’s lives have been touched by ALS, a truly horrible disease. CBC’s first Head Brewer, Darryl Goss, battled the disease for six years before succumbing in 2012. The Ales for ALS campaign will raise greater awareness and further research to find a cure, and we honor our friend Darryl with this beer as well as those people who continue to struggle against this disease, and the men and women dedicated to its eradication. Thanks for enjoying this exceptional beer, and more importantly for joining us in the fight to cure ALS. Cheers! Teardrop 6[/wpex]

Original Gravity
1.049

Final Gravity
1.011

Alcohol By Volume
5.0%